GALWAY, IRELAND--September 14, 2022--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--MSD Ireland, part of Merck & Co. (NYSE:MRK), has confirmed plans to begin construction on a state-of-the-art facility for the production of next-generation oncology biologics at its site in County Carlow, Ireland. Within this article: Details plant investment, jobs, products, timeline, related investment, state of Ireland's pharma sector
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
